Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Doria

Showing results (121-130 of 139) with videos related to

Pageof 14
Sort By:
Journal of the American Society of Nephrology : JASN|February 21, 2025
Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney DiseaseVikas S Sridhar, Luxcia Kugathasan, Leif Erik Lovblom, et al.
Diabetes|April 14, 2018
Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 DiabetesDaniel M Rotroff, Sook Wah Yee, Kaixin Zhou, et al.
Atherosclerosis|October 31, 2012
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistanceSimonetta Bacci, Sabrina Prudente, Massimiliano Copetti, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 7, 2025
Modeling Cardiorenal Protection with Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes: An Analysis of DEPICT-1 and DEPICT-2Massimo Nardone, Luxcia Kugathasan, Vikas S Sridhar, et al.
Diabetes|February 2, 2011
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patientsSimonetta Bacci, Stefano Rizza, Sabrina Prudente, et al.
Diabetes Care|March 18, 2025
Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?Luxcia Kugathasan, Pritha Dutta, Massimo Nardone, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2021
Gain of Function of Malate Dehydrogenase 2 and Familial HyperglycemiaPrapaporn Jungtrakoon Thamtarana, Antonella Marucci, Luca Pannone, et al.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Cell Metabolism|December 25, 2015
SerpinB1 Promotes Pancreatic β Cell ProliferationAbdelfattah El Ouaamari, Ercument Dirice, Nicholas Gedeon, et al.
Pageof 14

Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
Journal of the American Society of Nephrology : JASN|February 21, 2025
Indexing GFR Using Extracellular Volume versus Body Surface Area in a Population with Type 1 Diabetes and Diabetic Kidney DiseaseVikas S Sridhar, Luxcia Kugathasan, Leif Erik Lovblom, et al.
Diabetes|April 14, 2018
Genetic Variants in <i>CPA6</i> and <i>PRPF31</i> Are Associated With Variation in Response to Metformin in Individuals With Type 2 DiabetesDaniel M Rotroff, Sook Wah Yee, Kaixin Zhou, et al.
Atherosclerosis|October 31, 2012
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistanceSimonetta Bacci, Sabrina Prudente, Massimiliano Copetti, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 7, 2025
Modeling Cardiorenal Protection with Sodium-Glucose Cotransporter 2 Inhibition in Type 1 Diabetes: An Analysis of DEPICT-1 and DEPICT-2Massimo Nardone, Luxcia Kugathasan, Vikas S Sridhar, et al.
Diabetes|February 2, 2011
The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patientsSimonetta Bacci, Stefano Rizza, Sabrina Prudente, et al.
Diabetes Care|March 18, 2025
Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?Luxcia Kugathasan, Pritha Dutta, Massimo Nardone, et al.
The Journal of Clinical Endocrinology and Metabolism|October 31, 2021
Gain of Function of Malate Dehydrogenase 2 and Familial HyperglycemiaPrapaporn Jungtrakoon Thamtarana, Antonella Marucci, Luca Pannone, et al.
Science Translational Medicine|August 10, 2022
Neuroblastoma suppressor of tumorigenicity 1 is a circulating protein associated with progression to end-stage kidney disease in diabetesHiroki Kobayashi, Helen C Looker, Eiichiro Satake, et al.
Nature Medicine|April 24, 2019
A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesMonika A Niewczas, Meda E Pavkov, Jan Skupien, et al.
Cell Metabolism|December 25, 2015
SerpinB1 Promotes Pancreatic β Cell ProliferationAbdelfattah El Ouaamari, Ercument Dirice, Nicholas Gedeon, et al.
Pageof 14